Company intelligence / Profile preview

BioSeek

South San Francisco, California, United States

Ownership: Private
Development stage: Commercial

Overview

BioSeek developed the BioMAP Systems platform—a suite of predictive primary human cell-based disease models that generate activity profiles for potential drugs. This enables early insight into pharmacological properties, mechanism-of-action characterization, biomarker identification, on/off-target effects assessment, and indication selection. The company’s technology has been leveraged in collaborations with major pharmaceutical companies to improve R&D productivity across multiple therapeutic areas. In November 2012, it was acquired by DiscoveRx.

Therapeutic areas: PulmonologyCardiovascularRheumatologyImmunology
Modalities: Small moleculeBiologic
Industry: Drug Discovery Services

Partnerships

Lexicon PharmaceuticalsUCB Pharma

Beyond the preview

Go deeper on BioSeek.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioSeek.

Explore the full profile